Acquisitions - Identifiable Intangible Assets Acquired - Total Intangible Assets (Details) - Neos Therapeutics, Inc. $ in Thousands	Mar. 19, 2021 USD ($)
Business Acquisition [Line Items]
Indefinite-lived intangible assets acquired, In-process R&D	$ 2,600
Total intangible assets acquired	$ 56,530

Amount of intangible assets, excluding goodwill, acquired at the acquisition date.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472

Name:	us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant